Hoosier Research Leads to FDA Approval for Bleeding Disorder Drug
The U.S. Food and Drug Administration recently approved a drug for the treatment of patients with an ultra-rare bleeding disorder. Ryplazim was developed by Canada-based Liminal Biosciences Inc. and i... Read More
